Mutations of Chromatin and its Modifying Machineries in Malignancies

恶性肿瘤中染色质及其修饰机制的突变

基本信息

  • 批准号:
    9754580
  • 负责人:
  • 金额:
    $ 79.71万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2015
  • 资助国家:
    美国
  • 起止时间:
    2015-08-13 至 2022-07-31
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): Our studies have focused on the characterization of the molecular functions and biochemical properties of the Set1/MLL family of proteins and how their chimeras and mutations are associated with childhood leukemia and other forms of cancer. We have also focused on the role of chromatin and transcriptional elongation machinery in the regulation of developmental gene expression and how the misregulation of their activities is associated with malignancies. Our hope is that our molecular studies will advance our understanding of the molecular mechanisms of rearrangement-based and mutation-based cancer through the epigenetic regulators. Our biochemical and molecular studies demonstrated that Set1 in yeast exists in the Set1/COMPASS complex capable of methylating lysine 4 of histone H3 (H3K4). We demonstrated that Drosophila cells possess three Set1-related proteins and mammalian cells have six Set1-related proteins all found within COMPASS-like compositions capable of methylating histone H3K4. Furthermore, given that there is almost no sequence homology between many of the MLL translocation partners, for many years, it was unclear why MLL translocations into so many unrelated genes result in the pathogenesis of leukemia. Our biochemical studies on the purification of the MLL-chimeras demonstrated that many of the MLL translocation partners are part of the same macromolecular complex we named the Super Elongation Complex (SEC). We demonstrated that the translocations of MLL within any of the subunits of SEC subunits result in the misrecruitment of SEC to the MLL target genes and in the perturbation of the transcriptional checkpoint control of these genes, triggering leukemic growth. Additionally, the recent cataloging of somatic mutations in cancer identified a large number of mutations in the components of the MLL1-4 and Set1A/B complexes in both hematological malignancies and solid tumors. However, we know very little why the COMPASS family is mutated in different cancers. Given that we have developed a fantastic set of reagents and tools over the past seventeen years towards these factors and their associated proteins, chromatin, and other chromatin modifiers in multiple model systems; my laboratory is in a very unique position to define the molecular bases of these factors' involvement in cancer pathogenesis for the purpose of targeted therapeutics. Therefore, the goals of this R35 application is the full molecular and biochemical characterization of the COMPASS family, the translocation partners within the Super Elongation Complex (SEC), and the role of chromatin itself in the regulation of gene expression and development, and how their mutations contribute to the pathogenesis of human cancer.
 描述(由申请人证明):我们的研究集中在蛋白质的set1 /mll家族的分子功能和生化特性上,以及嵌合体和突变与儿童白血病和其他形式的癌症如何相关。染色质和转录伸长机械在发育基因表达的调节中的作用以及如何对thair vities的造成不利的作用,这将使我们对基于NT的基于NT和基于突变的癌症的理解能够促进表观遗传调节剂4。在组蛋白H3(H3K4)中,我们证明了果蝇细胞具有三个与甲基化组蛋白H3K4的蛋白质相关的蛋白质和哺乳动物LS的六个蛋白质。 ,这是l易解为许多无关的基因,导致白血病的发病机理是同一大分子的一部分。这些基因的检查中的基因,触发了白血病的生长,癌症癌症中癌症中癌症中癌症的癌症的近期分组MALIGNAGNANC和实体肿瘤很少。参与癌症的发病机理R的更多目的是靶向治疗的目标。在发育的调节中,以及mut突变如何促进humancancer的发病机理。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Ali Shilatifard其他文献

Ali Shilatifard的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Ali Shilatifard', 18)}}的其他基金

Epigenetics, Metabolism and Cancer
表观遗传学、新陈代谢和癌症
  • 批准号:
    10712221
  • 财政年份:
    2023
  • 资助金额:
    $ 79.71万
  • 项目类别:
Mutations of Chromatin and its Modifying Machineries in Malignancies
恶性肿瘤中染色质及其修饰机制的突变
  • 批准号:
    10705758
  • 财政年份:
    2015
  • 资助金额:
    $ 79.71万
  • 项目类别:
Mutations of Chromatin and its Modifying Machineries in Malignancies
恶性肿瘤中染色质及其修饰机制的突变
  • 批准号:
    9126472
  • 财政年份:
    2015
  • 资助金额:
    $ 79.71万
  • 项目类别:
Mutations of Chromatin and its Modifying Machineries in Malignancies
恶性肿瘤中染色质及其修饰机制的突变
  • 批准号:
    10224897
  • 财政年份:
    2015
  • 资助金额:
    $ 79.71万
  • 项目类别:
Mutations of Chromatin and its Modifying Machineries in Malignancies
恶性肿瘤中染色质及其修饰机制的突变
  • 批准号:
    10518587
  • 财政年份:
    2015
  • 资助金额:
    $ 79.71万
  • 项目类别:
The COMPASS family of H3K4 methylases in development and cancer
H3K4 甲基化酶 COMPASS 家族在发育和癌症中的作用
  • 批准号:
    8759914
  • 财政年份:
    2010
  • 资助金额:
    $ 79.71万
  • 项目类别:
Mammalian H3K4 Methylases, Chromosomal Translocations and Human Leukemia
哺乳动物 H3K4 甲基化酶、染色体易位和人类白血病
  • 批准号:
    8403710
  • 财政年份:
    2010
  • 资助金额:
    $ 79.71万
  • 项目类别:
Mammalian H3K4 Methylases, Chromosomal Translocations and Human Leukemia
哺乳动物 H3K4 甲基化酶、染色体易位和人类白血病
  • 批准号:
    8595296
  • 财政年份:
    2010
  • 资助金额:
    $ 79.71万
  • 项目类别:
Mammalian H3K4 Methylases, Chromosomal Translocations and Human Leukemia
哺乳动物 H3K4 甲基化酶、染色体易位和人类白血病
  • 批准号:
    8204739
  • 财政年份:
    2010
  • 资助金额:
    $ 79.71万
  • 项目类别:
Mammalian H3K4 Methylases, Chromosomal Translocations and Human Leukemia
哺乳动物 H3K4 甲基化酶、染色体易位和人类白血病
  • 批准号:
    8041000
  • 财政年份:
    2010
  • 资助金额:
    $ 79.71万
  • 项目类别:

相似国自然基金

真核病原微生物抗原表位的高效分类模型及多肽疫苗靶点筛选研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
基于全新理论体系推论式模型的若干两组间比较统计推断方法及其样本量估计方法的研究
  • 批准号:
    81803327
  • 批准年份:
    2018
  • 资助金额:
    21.0 万元
  • 项目类别:
    青年科学基金项目
变化“水深”环境下鄱阳湖湿地植被优势群落时空格局遥感研究
  • 批准号:
    41671338
  • 批准年份:
    2016
  • 资助金额:
    65.0 万元
  • 项目类别:
    面上项目
基于特征挖掘和机器学习的细菌VI型分泌系统效应分子的功能分类、计算预测和实验验证
  • 批准号:
    31571352
  • 批准年份:
    2015
  • 资助金额:
    57.0 万元
  • 项目类别:
    面上项目
基于经典方的中药生物药剂学分类系统的构建研究
  • 批准号:
    81473362
  • 批准年份:
    2014
  • 资助金额:
    73.0 万元
  • 项目类别:
    面上项目

相似海外基金

Elucidating the Biosynthesis of a Model Ladder-Frame Polyether Toxin
阐明梯架聚醚毒素模型的生物合成
  • 批准号:
    10810195
  • 财政年份:
    2023
  • 资助金额:
    $ 79.71万
  • 项目类别:
How Do a Few Attached Staphylococcus aureus Bacteria Evade Innate Immunity to Initiate Biofilm Infection on an Implanted Medical Device?
一些附着的金黄色葡萄球菌如何逃避先天免疫,在植入的医疗设备上引发生物膜感染?
  • 批准号:
    10387835
  • 财政年份:
    2021
  • 资助金额:
    $ 79.71万
  • 项目类别:
Elucidating the Biosynthesis of a Model Ladder-Frame Polyether Toxin
阐明梯架聚醚毒素模型的生物合成
  • 批准号:
    10254261
  • 财政年份:
    2020
  • 资助金额:
    $ 79.71万
  • 项目类别:
Elucidating the Biosynthesis of a Model Ladder-Frame Polyether Toxin
阐明梯架聚醚毒素模型的生物合成
  • 批准号:
    10066290
  • 财政年份:
    2020
  • 资助金额:
    $ 79.71万
  • 项目类别:
Elucidating the Biosynthesis of a Model Ladder-Frame Polyether Toxin
阐明梯架聚醚毒素模型的生物合成
  • 批准号:
    10469542
  • 财政年份:
    2020
  • 资助金额:
    $ 79.71万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了